These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2690419)

  • 1. An in vivo study on the effect of the immunosuppressant drug cyclosporin in malaria-infected mice.
    Somasundaram C; Ng ML; Sinniah R
    Trans R Soc Trop Med Hyg; 1989; 83(1):71. PubMed ID: 2690419
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimalarial activity of cyclosporins A, C and D.
    Uadia PO; Ezeamuzie IC; Ladan MJ; Gerrets R
    Afr J Med Med Sci; 1994 Mar; 23(1):47-51. PubMed ID: 7839946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimalarial activity of cyclosporin A.
    Thommen-Scott K
    Agents Actions; 1981 Dec; 11(6-7):770-3. PubMed ID: 7041571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of rodent malaria with levamisole.
    Hegazi MM; Abo-Shady AF; Abdel-Magied S
    J Egypt Soc Parasitol; 1981 Jun; 11(1):195-9. PubMed ID: 7028880
    [No Abstract]   [Full Text] [Related]  

  • 5. Lead decreases parasitemia and enhances survival of Plasmodium berghei-infected mice.
    Koka S; Huber SM; Boini KM; Lang C; Föller M; Lang F
    Biochem Biophys Res Commun; 2007 Nov; 363(3):484-9. PubMed ID: 17888870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei.
    White KL; Snyder HL; Krzych U
    J Immunol; 1996 May; 156(9):3374-81. PubMed ID: 8617963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimalarial effect of cyclosporin-A on murine P. berghei and human P. falciparum.
    Biswas S; Saxena QB; Upender M
    Indian J Malariol; 1991 Mar; 28(1):1-8. PubMed ID: 1915980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of Plasmodium berghei and the immunosuppression phenomenon in the early phase of experimental malaria in mice].
    Gilpin-Jackson E; Shadrin BP; Liakh AG
    Med Parazitol (Mosk); 1988; (5):9-11. PubMed ID: 3075262
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of murine cerebral malaria by low-dose cyclosporin A.
    Grau GE; Gretener D; Lambert PH
    Immunology; 1987 Aug; 61(4):521-5. PubMed ID: 3327806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron deficiency influences the course of malaria in Plasmodium berghei infected mice.
    Koka S; Föller M; Lamprecht G; Boini KM; Lang C; Huber SM; Lang F
    Biochem Biophys Res Commun; 2007 Jun; 357(3):608-14. PubMed ID: 17445762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studying the effect of chloroquine on sporozoite-induced protection and immune responses in Plasmodium berghei malaria.
    Bijker EM; Nganou-Makamdop K; van Gemert GJ; Zavala F; Cockburn I; Sauerwein RW
    Malar J; 2015 Mar; 14():130. PubMed ID: 25889324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of antimalarial treatment on acquisition of immunity in Plasmodium berghei NK65 malaria.
    Long TT; Nakazawa S; Huaman MC; Kanbara H
    Clin Diagn Lab Immunol; 2002 Jul; 9(4):933-4. PubMed ID: 12093701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superoxide dismutase (SOD) in mouse red blood cells infected with Plasmodium berghei.
    Suthipark U; Krungkrai J; Jearnpipatkul A; Yuthavong Y; Panijpan B
    J Parasitol; 1982 Apr; 68(2):337-9. PubMed ID: 7042950
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphocyte trapping and malaria in Plasmodium-berghei-infected mice.
    Bitzan M; Spira DT
    Isr J Med Sci; 1978 Jun; 14(6):673-81. PubMed ID: 355201
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunopathological studies of Plasmodium berghei berghei-infected mice: effect of cyclophosphamide.
    Endardjo S; Boonpucknavig S; Boonpucknavig V; Bhamarapravati N
    J Trop Med Hyg; 1978; 81(2-3):25-31. PubMed ID: 347101
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of the antimalarial activity of new compounds against Plasmodium falciparum in vitro, and Plasmodium berghei in vivo.
    Tedlaouti F; Gasquet M; Delmas F; Timon-David P; Madadi NE; Vanelle P; Maldonado J
    J Pharm Belg; 1990; 45(5):306-10. PubMed ID: 2086754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-Cell Immunoglobulin- and Mucin-Domain-Containing Molecule 3 Signaling Blockade Improves Cell-Mediated Immunity Against Malaria.
    Hou N; Zou Y; Piao X; Liu S; Wang L; Li S; Chen Q
    J Infect Dis; 2016 Nov; 214(10):1547-1556. PubMed ID: 27638944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural immunization against malaria: causal prophylaxis with antibiotics.
    Friesen J; Silvie O; Putrianti ED; Hafalla JC; Matuschewski K; Borrmann S
    Sci Transl Med; 2010 Jul; 2(40):40ra49. PubMed ID: 20630856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppression induced by Plasmodium berghei and P. chabaudi infections in mice.
    Tanabe K
    Osaka City Med J; 1978; 24(1):73-90. PubMed ID: 377186
    [No Abstract]   [Full Text] [Related]  

  • 20. Primaquine-thiazolidinones block malaria transmission and development of the liver exoerythrocytic forms.
    Aguiar AC; Figueiredo FJ; Neuenfeldt PD; Katsuragawa TH; Drawanz BB; Cunico W; Sinnis P; Zavala F; Krettli AU
    Malar J; 2017 Mar; 16(1):110. PubMed ID: 28279180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.